Free Trial

Givaudan SA (OTCMKTS:GVDNY) Receives Average Rating of "Hold" from Brokerages

Givaudan logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • The seven analysts covering Givaudan give a consensus rating of "Hold", with a breakdown of 2 sells, 3 holds and 2 buys.
  • Sentiment is mixed: Deutsche Bank reissued a buy, while Goldman Sachs cut the stock to a sell and both Barclays and Berenberg downgraded it to hold.
  • Givaudan opened at $71.82, trading below its 200-day moving average of $78.57 and inside a 52-week range of $65.97 to $103.39, suggesting subdued price momentum.
  • MarketBeat previews the top five stocks to own by May 1st.

Shares of Givaudan SA (OTCMKTS:GVDNY - Get Free Report) have received a consensus recommendation of "Hold" from the seven ratings firms that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company.

A number of analysts have weighed in on GVDNY shares. Deutsche Bank Aktiengesellschaft reissued a "buy" rating on shares of Givaudan in a research report on Friday, January 30th. Barclays downgraded shares of Givaudan from a "strong-buy" rating to a "hold" rating in a research report on Friday, March 27th. Berenberg Bank downgraded shares of Givaudan from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, March 31st. The Goldman Sachs Group downgraded shares of Givaudan from a "strong-buy" rating to a "sell" rating in a research report on Tuesday, February 10th. Finally, Citigroup reissued a "neutral" rating on shares of Givaudan in a research report on Tuesday, February 3rd.

Read Our Latest Report on Givaudan

Givaudan Stock Performance

OTCMKTS:GVDNY opened at $71.82 on Friday. The company has a 50 day simple moving average of $72.62 and a two-hundred day simple moving average of $78.57. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.74 and a quick ratio of 1.13. Givaudan has a fifty-two week low of $65.97 and a fifty-two week high of $103.39.

About Givaudan

(Get Free Report)

Givaudan is a Swiss-based global company that develops, manufactures and supplies flavors, fragrances and active cosmetic ingredients for a broad range of consumer products. The company's core activities are organized around creating taste and scent solutions—ranging from fine fragrances and consumer-packaged goods scents to flavor systems for food and beverages and functional ingredients for personal care. Givaudan works with brand owners and manufacturers to design sensory experiences, improve product performance and meet formulation or regulatory requirements.

Its product and service offerings include bespoke fragrance creation, flavor formulation, natural ingredient sourcing, aroma chemicals, taste modulators and application support such as prototyping and sensory testing.

Read More

Analyst Recommendations for Givaudan (OTCMKTS:GVDNY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Givaudan Right Now?

Before you consider Givaudan, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Givaudan wasn't on the list.

While Givaudan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines